Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cell therapy
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
deals
gene therapy
investing
merck
startups
alzheimer's disease
autoimmune diseases
cancer
cancer immunotherapy
clinical trials
duchenne muscular dystrophy
fda
What
bio
5
×
roundup
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
drug
efforts
meso’s
miss
new
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
advantages
ahead
approval
asco
bar
biogen’s
biopharmaceutical
branded
brings
choices
commissioner
companies
consumers
convo
costly
counterweight
drugs
Language
unset
Current search:
photo
×
" cell therapy "
×
bio
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
